Compare NexgenRx, Inc. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 17.21%
2
The company is Net-Debt Free
3
With a growth in Net Profit of 132.98%, the company declared Very Positive results in Mar 26
4
With ROE of 24.41%, it has a very attractive valuation with a 3.79 Price to Book Value
5
Market Beating performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
66.67%
0%
66.67%
6 Months
55.84%
0%
55.84%
1 Year
71.43%
0%
71.43%
2 Years
140.0%
0%
140.0%
3 Years
100.0%
0%
100.0%
4 Years
71.43%
0%
71.43%
5 Years
66.67%
0%
66.67%
NexgenRx, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.72%
EBIT Growth (5y)
10.73%
EBIT to Interest (avg)
0.96
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-3.16
Sales to Capital Employed (avg)
1.93
Tax Ratio
24.49%
Dividend Payout Ratio
100.67%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
17.21%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
3.79
EV to EBIT
-0.75
EV to EBITDA
-0.52
EV to Capital Employed
0.07
EV to Sales
-0.11
PEG Ratio
0.07
Dividend Yield
NA
ROCE (Latest)
-9.72%
ROE (Latest)
24.41%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
4.90
4.40
11.36%
Operating Profit (PBDIT) excl Other Income
1.40
0.80
75.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.20
0.50
140.00%
Operating Profit Margin (Excl OI)
233.30%
100.60%
13.27%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 11.36% vs 7.32% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 140.00% vs 0.00% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
17.50
15.90
10.06%
Operating Profit (PBDIT) excl Other Income
3.00
1.90
57.89%
Interest
0.20
0.20
Exceptional Items
-0.20
0.00
Consolidate Net Profit
1.30
0.60
116.67%
Operating Profit Margin (Excl OI)
101.70%
39.00%
6.27%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 10.06% vs 19.55% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 116.67% vs 300.00% in Dec 2024
About NexgenRx, Inc. 
NexgenRx, Inc.
Miscellaneous
NexgenRx Inc. (NexgenRx) administers, adjudicates and pays drug, dental and other extended healthcare claims for the beneficiaries of health benefit plans underwritten by its customers, using computer software. The Company is engaged in the sale of its administration and health benefit claims adjudication services to organizations managing health benefit plans on behalf of plan sponsors, such as employers and associations, among others, and to the Canadian plan sponsors providing an Administrative Services Only (ASO) health benefit plan to their plan members. The health benefit claims include drug, dental, extended health and healthcare spending account claims. The Company sells its service on a fee-per-transaction basis, in addition to per member administration fees. The Company's Web-based product, theclaimsXchange.com, offers a platform, which allows various extended health providers to submit claims on behalf of their patients for benefits through a Web portal.
Company Coordinates 
Company Details
185 The West Mall, Suite 600 , TORONTO CA : M9C 5L5
Registrar Details






